^ Interesting sentiment there Sidage. I concur.
However, there is a question of how much should each patient be worth in future revenues?
Balance Sheets tell us certainly not enough to warrant this high a MC, so what is the acceptable sort of metric to value these patients?
AFAIK AGH has 1500+ patients, likely closing in on 2000 now. Is that worth 150-200M MC? Obviously partnering with CannVaLate is huge and the reason why patient growth is so exponential.
If anyone would like to share their valuation metrics here would be welcome to hear it.
Rebound time, page-567
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.002(8.00%) |
Mkt cap ! $10.94M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $45.16K | 1.746M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1010657 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 786608 | 5 |
View Market Depth
| Last trade - 14.32pm 13/09/2024 (20 minute delay) ? |
| AGH (ASX) Chart |